Author

Pei-Ming Yang

h-index 6 View on Semantic Scholar

We have 1 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Fedratinib induces non-classical G2/M arrest via mitotic-kinase inhibition and synergizes with mitomycin C to suppress pancreatic ductal adenocarcinoma.

Findings highlight fedratinib as a promising repurposed therapeutic agent for PDAC and support its combination with mitomycin C as a potential new treatment strategy.

Hui-Ying Li, Pei-Ming Yang · Molecular Cancer Therapeutic... · 0 citations